Chemotherapy-Induced Myelosuppression Treatments Market - Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: CBB9FFB4D03AEN
Market Monitor Global

Abstracts

Chemotherapy-Induced myelosuppression is defined as the decreased ability of the bone marrow to produce blood cells (WBC, RBC and platelets). It occurs most commonly in cancer patients as an adverse effect of chemotherapy drugs, especially in case of cancers that are located near the bone marrow or near large bones with cavities.

This report contains market size and forecasts of Chemotherapy-Induced Myelosuppression Treatments in Global, including the following market information:

Global Chemotherapy-Induced Myelosuppression Treatments Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Chemotherapy-Induced Myelosuppression Treatments market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chemotherapy-Induced Myelosuppression Treatments include Amgen, Teva Pharmaceutical, Pfizer and Janssen Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chemotherapy-Induced Myelosuppression Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chemotherapy-Induced Myelosuppression Treatments Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Chemotherapy-Induced Myelosuppression Treatments Market Segment Percentages, by Type, 2021 (%)

• Oral
• Injection

Global Chemotherapy-Induced Myelosuppression Treatments Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Chemotherapy-Induced Myelosuppression Treatments Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Global Chemotherapy-Induced Myelosuppression Treatments Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Chemotherapy-Induced Myelosuppression Treatments Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chemotherapy-Induced Myelosuppression Treatments revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Chemotherapy-Induced Myelosuppression Treatments revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen
• Teva Pharmaceutical
• Pfizer
• Janssen Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Chemotherapy-Induced Myelosuppression Treatments Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Chemotherapy-Induced Myelosuppression Treatments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CHEMOTHERAPY-INDUCED MYELOSUPPRESSION TREATMENTS OVERALL MARKET SIZE

2.1 Global Chemotherapy-Induced Myelosuppression Treatments Market Size: 2021 VS 2028
2.2 Global Chemotherapy-Induced Myelosuppression Treatments Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Chemotherapy-Induced Myelosuppression Treatments Players in Global Market
3.2 Top Global Chemotherapy-Induced Myelosuppression Treatments Companies Ranked by Revenue
3.3 Global Chemotherapy-Induced Myelosuppression Treatments Revenue by Companies
3.4 Top 3 and Top 5 Chemotherapy-Induced Myelosuppression Treatments Companies in Global Market, by Revenue in 2021
3.5 Global Companies Chemotherapy-Induced Myelosuppression Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chemotherapy-Induced Myelosuppression Treatments Players in Global Market
  3.6.1 List of Global Tier 1 Chemotherapy-Induced Myelosuppression Treatments Companies
  3.6.2 List of Global Tier 2 and Tier 3 Chemotherapy-Induced Myelosuppression Treatments Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Chemotherapy-Induced Myelosuppression Treatments Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Injection
4.2 By Type - Global Chemotherapy-Induced Myelosuppression Treatments Revenue & Forecasts
  4.2.1 By Type - Global Chemotherapy-Induced Myelosuppression Treatments Revenue, 2017-2022
  4.2.2 By Type - Global Chemotherapy-Induced Myelosuppression Treatments Revenue, 2023-2028
  4.2.3 By Type - Global Chemotherapy-Induced Myelosuppression Treatments Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Chemotherapy-Induced Myelosuppression Treatments Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Online Pharmacies
  5.1.4 Retail Pharmacies
5.2 By Application - Global Chemotherapy-Induced Myelosuppression Treatments Revenue & Forecasts
  5.2.1 By Application - Global Chemotherapy-Induced Myelosuppression Treatments Revenue, 2017-2022
  5.2.2 By Application - Global Chemotherapy-Induced Myelosuppression Treatments Revenue, 2023-2028
  5.2.3 By Application - Global Chemotherapy-Induced Myelosuppression Treatments Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Chemotherapy-Induced Myelosuppression Treatments Market Size, 2021 & 2028
6.2 By Region - Global Chemotherapy-Induced Myelosuppression Treatments Revenue & Forecasts
  6.2.1 By Region - Global Chemotherapy-Induced Myelosuppression Treatments Revenue, 2017-2022
  6.2.2 By Region - Global Chemotherapy-Induced Myelosuppression Treatments Revenue, 2023-2028
  6.2.3 By Region - Global Chemotherapy-Induced Myelosuppression Treatments Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Chemotherapy-Induced Myelosuppression Treatments Revenue, 2017-2028
  6.3.2 US Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.3.3 Canada Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.3.4 Mexico Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Chemotherapy-Induced Myelosuppression Treatments Revenue, 2017-2028
  6.4.2 Germany Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.4.3 France Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.4.4 U.K. Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.4.5 Italy Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.4.6 Russia Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.4.7 Nordic Countries Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.4.8 Benelux Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Chemotherapy-Induced Myelosuppression Treatments Revenue, 2017-2028
  6.5.2 China Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.5.3 Japan Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.5.4 South Korea Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.5.5 Southeast Asia Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.5.6 India Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Chemotherapy-Induced Myelosuppression Treatments Revenue, 2017-2028
  6.6.2 Brazil Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.6.3 Argentina Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Chemotherapy-Induced Myelosuppression Treatments Revenue, 2017-2028
  6.7.2 Turkey Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.7.3 Israel Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.7.4 Saudi Arabia Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028
  6.7.5 UAE Chemotherapy-Induced Myelosuppression Treatments Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amgen
  7.1.1 Amgen Corporate Summary
  7.1.2 Amgen Business Overview
  7.1.3 Amgen Chemotherapy-Induced Myelosuppression Treatments Major Product Offerings
  7.1.4 Amgen Chemotherapy-Induced Myelosuppression Treatments Revenue in Global Market (2017-2022)
  7.1.5 Amgen Key News
7.2 Teva Pharmaceutical
  7.2.1 Teva Pharmaceutical Corporate Summary
  7.2.2 Teva Pharmaceutical Business Overview
  7.2.3 Teva Pharmaceutical Chemotherapy-Induced Myelosuppression Treatments Major Product Offerings
  7.2.4 Teva Pharmaceutical Chemotherapy-Induced Myelosuppression Treatments Revenue in Global Market (2017-2022)
  7.2.5 Teva Pharmaceutical Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Chemotherapy-Induced Myelosuppression Treatments Major Product Offerings
  7.3.4 Pfizer Chemotherapy-Induced Myelosuppression Treatments Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Janssen Pharmaceutical
  7.4.1 Janssen Pharmaceutical Corporate Summary
  7.4.2 Janssen Pharmaceutical Business Overview
  7.4.3 Janssen Pharmaceutical Chemotherapy-Induced Myelosuppression Treatments Major Product Offerings
  7.4.4 Janssen Pharmaceutical Chemotherapy-Induced Myelosuppression Treatments Revenue in Global Market (2017-2022)
  7.4.5 Janssen Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Chemotherapy-Induced Myelosuppression Treatments Market Opportunities & Trends in Global Market
Table 2. Chemotherapy-Induced Myelosuppression Treatments Market Drivers in Global Market
Table 3. Chemotherapy-Induced Myelosuppression Treatments Market Restraints in Global Market
Table 4. Key Players of Chemotherapy-Induced Myelosuppression Treatments in Global Market
Table 5. Top Chemotherapy-Induced Myelosuppression Treatments Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Chemotherapy-Induced Myelosuppression Treatments Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Chemotherapy-Induced Myelosuppression Treatments Revenue Share by Companies, 2017-2022
Table 8. Global Companies Chemotherapy-Induced Myelosuppression Treatments Product Type
Table 9. List of Global Tier 1 Chemotherapy-Induced Myelosuppression Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chemotherapy-Induced Myelosuppression Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Chemotherapy-Induced Myelosuppression Treatments Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Chemotherapy-Induced Myelosuppression Treatments Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Chemotherapy-Induced Myelosuppression Treatments Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Chemotherapy-Induced Myelosuppression Treatments Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Chemotherapy-Induced Myelosuppression Treatments Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Chemotherapy-Induced Myelosuppression Treatments Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Chemotherapy-Induced Myelosuppression Treatments Product Offerings
Table 32. Amgen Chemotherapy-Induced Myelosuppression Treatments Revenue (US$, Mn), (2017-2022)
Table 33. Teva Pharmaceutical Corporate Summary
Table 34. Teva Pharmaceutical Chemotherapy-Induced Myelosuppression Treatments Product Offerings
Table 35. Teva Pharmaceutical Chemotherapy-Induced Myelosuppression Treatments Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Chemotherapy-Induced Myelosuppression Treatments Product Offerings
Table 38. Pfizer Chemotherapy-Induced Myelosuppression Treatments Revenue (US$, Mn), (2017-2022)
Table 39. Janssen Pharmaceutical Corporate Summary
Table 40. Janssen Pharmaceutical Chemotherapy-Induced Myelosuppression Treatments Product Offerings
Table 41. Janssen Pharmaceutical Chemotherapy-Induced Myelosuppression Treatments Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Chemotherapy-Induced Myelosuppression Treatments Segment by Type in 2021
Figure 2. Chemotherapy-Induced Myelosuppression Treatments Segment by Application in 2021
Figure 3. Global Chemotherapy-Induced Myelosuppression Treatments Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chemotherapy-Induced Myelosuppression Treatments Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chemotherapy-Induced Myelosuppression Treatments Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chemotherapy-Induced Myelosuppression Treatments Revenue in 2021
Figure 8. By Type - Global Chemotherapy-Induced Myelosuppression Treatments Revenue Market Share, 2017-2028
Figure 9. By Application - Global Chemotherapy-Induced Myelosuppression Treatments Revenue Market Share, 2017-2028
Figure 10. By Region - Global Chemotherapy-Induced Myelosuppression Treatments Revenue Market Share, 2017-2028
Figure 11. By Country - North America Chemotherapy-Induced Myelosuppression Treatments Revenue Market Share, 2017-2028
Figure 12. US Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Chemotherapy-Induced Myelosuppression Treatments Revenue Market Share, 2017-2028
Figure 16. Germany Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 17. France Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Chemotherapy-Induced Myelosuppression Treatments Revenue Market Share, 2017-2028
Figure 24. China Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 28. India Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Chemotherapy-Induced Myelosuppression Treatments Revenue Market Share, 2017-2028
Figure 30. Brazil Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Chemotherapy-Induced Myelosuppression Treatments Revenue Market Share, 2017-2028
Figure 33. Turkey Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Chemotherapy-Induced Myelosuppression Treatments Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Chemotherapy-Induced Myelosuppression Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceutical Chemotherapy-Induced Myelosuppression Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Chemotherapy-Induced Myelosuppression Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Janssen Pharmaceutical Chemotherapy-Induced Myelosuppression Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)